This is a rare genetic disorder affecting sugar breakdown. It causes sugars to build up in the body, leading to physical and mental health problems. There are different types (A, B) caused by different missing enzymes.
Every report comes from a Lived member, sent anonymously.
Have you tried Enzyme Replacement Therapy for Morquio Syndrome (MPS IV)?
Morquio syndrome, also called mucopolysaccharidosis type IV (MPS IV), is a rare inherited condition that mainly affects the bones and joints. The body cannot fully break down certain long sugar molecules called glycosaminoglycans, so they build up inside cells, especially in bone and cartilage. Over time this changes how the skeleton grows and holds together. Signs usually appear in early childhood. Children may have short stature, knock-knees, a prominent breastbone, a curved spine and changes in the hips and wrists. Joints are often unusually loose, which can make walking unsteady, although some joints become stiff. A key concern is the top of the neck: a small peg of bone that normally keeps the upper spine stable is underdeveloped, so the neck bones can slip and press on the spinal cord. Cloudy corneas (the clear front of the eye), hearing loss, a narrow airway, sleep apnea, thin tooth enamel and heart valve changes are also common. MPS IV does not affect intelligence, which sets it apart from several other types of mucopolysaccharidosis. Severity varies widely. Some children show clear signs between ages 1 and 3 and progress quickly, while others have a milder form that may not be noticed until adolescence, often as hip pain and stiffness.
MPS IV is caused by changes in a single gene, and nothing a parent or child did brings it on. There are two types. MPS IVA (Morquio A) comes from changes in the GALNS gene, and MPS IVB (Morquio B) from changes in the GLB1 gene. Each gene carries instructions for an enzyme that breaks down glycosaminoglycans; when the enzyme is missing or works poorly, these molecules accumulate. MPS IVB tends to have fewer and milder features, but the two types cannot be told apart by symptoms alone. The condition is inherited in an autosomal recessive pattern. A child is affected only when they receive a changed copy of the gene from each parent. Parents who each carry one changed copy are usually healthy, and with each pregnancy they have a 25% (one in four) chance of having an affected child. Genetic counseling can explain the chances for other family members.
Diagnosis often starts with a child's growth and skeletal changes, such as knock-knees, a short trunk or spinal curvature, along with X-rays showing the bone pattern typical of MPS. A urine test can show high levels of glycosaminoglycans, particularly one called keratan sulfate. This screening test is helpful but imperfect, because levels in teenagers and adults can overlap with normal values. The diagnosis is confirmed by measuring enzyme activity in blood or skin cells, by genetic testing that finds two disease-causing changes in the responsible gene, or both. This step matters because it determines whether a person has MPS IVA or MPS IVB, and only MPS IVA has an approved disease-specific treatment. The milder form can be mistaken at first for other hip or joint problems, such as juvenile arthritis or Legg-Calve-Perthes disease. After diagnosis, a full baseline assessment usually follows: MRI of the neck and spine, breathing and sleep studies, heart, eye and hearing checks, and walking tests that become reference points for later follow-up.
There is no cure for MPS IV, but treatment can slow some problems, protect the spinal cord and help people stay mobile and comfortable. Care is usually led by a specialist center with a team that may include metabolic doctors, orthopedic and spine surgeons, lung and heart specialists, physical and occupational therapists and psychologists. For MPS IVA, enzyme replacement therapy supplies a lab-made version of the missing enzyme. The approved medicine is elosulfase alfa (Vimizim), given as an intravenous infusion once a week that takes several hours. In the main trial, people treated weekly for 24 weeks walked about 22 meters further in a six-minute walk test than those given a placebo (an inactive infusion), a modest gain in walking endurance, with no difference in stair climbing. It may also help endurance and daily activities over the long term, but it has not been shown to correct bone deformities, and evidence for any effect on bone is limited. Infusions can cause allergic reactions, including anaphylaxis (a severe, whole-body allergic reaction), so they start in a clinic or hospital that can treat these reactions, with medicine given beforehand to reduce the risk. Anyone who develops trouble breathing, throat tightness or widespread hives after an infusion needs emergency care. There is no approved enzyme therapy for MPS IVB, and stem cell transplant is considered experimental for MPS IV. Surgery addresses the skeletal problems. Fusing the top of the spine, sometimes with surgery to relieve pressure on the spinal cord, can prevent permanent damage when the neck is unstable. Guided growth surgery in childhood can straighten knock-knees, and hip or spine surgery may be needed later. Removing tonsils and adenoids, CPAP (a mask that keeps the airway open during sleep) or other breathing support can treat sleep apnea. Hearing aids, ear tubes, regular dental care, pain management and, rarely, corneal transplant address other features. Anesthesia carries special risks because of the unstable neck and narrow airway. Surgery should take place at a center experienced with MPS, where the team checks the airway, heart and spine beforehand and keeps the neck in a neutral position throughout. When possible, procedures are combined to reduce the number of anesthetics.
MPS IV is lifelong and progressive, but the pace varies a great deal. People with milder forms usually live into adulthood, although life expectancy may be shortened. In severe forms, breathing problems and spinal cord compression are the main threats to life, which is why regular monitoring matters so much. Because thinking and learning are not affected, most children attend regular school. Practical adjustments help: sitting near the front for hearing or vision, a wheelchair for longer distances and occupational therapy tools for a weak grip. Many people use walking aids or a wheelchair as they get older, and joint pain and fatigue can become part of daily life. Follow-up is frequent. Children typically have spine MRIs every year, along with regular growth, breathing, sleep, heart, eye, hearing and dental checks. Those on enzyme therapy also plan their week around infusions. Families often find it useful to connect with an MPS patient organization and to have psychological or social work support.
Talk with a doctor if a child has knock-knees, a short trunk, an unusual spine or chest shape, or unexplained hip pain and stiffness, especially when there is a family history of MPS. Snoring, morning headaches or tiring easily are worth raising at the next visit, because they can point to sleep apnea or breathing problems. Contact the care team promptly about new or worsening weakness, numbness or tingling in the arms or legs, a change in walking or more frequent falls. These can be signs that the spinal cord is being compressed. Call 911 if someone with MPS IV suddenly cannot move or has sudden severe weakness in their arms or legs, especially after a fall or a blow to the head or neck. Even a minor fall can injure the spinal cord when the neck is unstable.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Morquio Syndrome (MPS IV) is like, what's helped you, or ask the community a question.